Neissena gonorrhoeae causes both localized uncomplicated infections at mucosal surfaces and more invasive forms of disease including pelvic inflammatory disease and disseminated gonococcal infection. The ability of gonococci to evade the antimicrobial action of mediators of innate host defense at mucosal surfaces or in the bloodstream is of likely importance in its ability to survive eariy during infection. In this project we will focus on determining whether mechanisms of gonococcal resistance to antimicrobial agents of innate host defense impact infectivity and/or in vivo fitness.
In Specific Aim 1 we will test the role of the MtrC-MtrD MtrE efflux pump in determining the ability of gonococci to Infect the male urethra. To our knowledge, this will be the first test of the importance of any microbial efflux pump in promoting an infection in humans. The MtrC-MtrD-MtrE efflux pump endows gonococci with a mechanism to export hydrophobic antibiotics and host-derived antimicrobials (antimicrobial peptides, bile salts and progesterone) that bathe mucosal surfaces. The proteins that fomn the pump are encoded by the mtrCDE operon, which is transcriptionally regulated by cis- and frans-acting regulatory control processes. These regulatory systems modulate levels of gonococcal fitness in a murine model of lower genital tract infection and we will now test if they also modulate in vivo fitness in humans.
In Specific Aim 2 we will determine whether mutations that alter lipooligosaccharide structure and are known to result in changes in gonococcal susceptibility to the killing action of normal human serum or cationic antimicrobial peptides impact gonococcal infectivity and/or in vivo fitness. We hypothesize that mediators of the innate host defense system function at the genital mucosal surface as antibiotics and as a consequence of their antimicrobial action against gonococci, resistant variants ultimately emerge and these have a competitive advantage during infection. Accordingly, in Specific Aim 3 we will isolate laboratory-derived mutants of gonococci with altered levels of susceptibility to host-derived antimicrobials and test if such strains have increased or decreased fitness in vivo. The results will provide important insights regarding the ability of gonococci to adapt to the in vivo environment.

Public Health Relevance

The goal of this project is to understand how the strict human pathogen Neisseria gonorrhoeae resists the natural host defenses that normally function during infection. The information gained from this investigation will help in the development of an effective vaccine to prevent gonorrhea, which remains a worid-wide public health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI031496-23
Application #
8519213
Study Section
Special Emphasis Panel (ZAI1-MMT-M)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
23
Fiscal Year
2013
Total Cost
$256,459
Indirect Cost
$40,589
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Kissinger, Patricia J; White, Scott; Manhart, Lisa E et al. (2016) Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis. Sex Transm Dis 43:599-602
Kandler, Justin L; Acevedo, Rosuany Vélez; Dickinson, Mary Kathryne et al. (2016) The genes that encode the gonococcal transferrin binding proteins, TbpB and TbpA, are differentially regulated by MisR under iron-replete and iron-depleted conditions. Mol Microbiol 102:137-51
Kandler, Justin L; Holley, Concerta L; Reimche, Jennifer L et al. (2016) The MisR Response Regulator Is Necessary for Intrinsic Cationic Antimicrobial Peptide and Aminoglycoside Resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 60:4690-700
Woolf-King, Sarah E; Muyindike, Winnie; Hobbs, Marcia M et al. (2016) Vaginal Prostate Specific Antigen (PSA) Is a Useful Biomarker of Semen Exposure Among HIV-Infected Ugandan Women. AIDS Behav :
Scheidell, Joy D; Lejuez, Carl W; Golin, Carol E et al. (2016) Borderline Personality Disorder Symptom Severity and Sexually Transmitted Infection and HIV Risk in African American Incarcerated Men. Sex Transm Dis 43:317-23
Samo, Melissa; Choudhary, Neelima R; Riebe, Kristina J et al. (2016) Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface. Vaccine 34:1193-200
Khan, M R; Golin, C E; Friedman, S R et al. (2015) STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use. AIDS Behav 19:1478-90
Unemo, Magnus; Shafer, William M (2015) Future treatment of gonorrhea--novel emerging drugs are essential and in progress? Expert Opin Emerg Drugs 20:357-60
Cash, Devin R; Noinaj, Nicholas; Buchanan, Susan K et al. (2015) Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae. Infect Immun 83:4438-49
Gallo, Maria F; Warner, Lee; Hobbs, Marcia M et al. (2015) Differences in misreporting of sexual behavior over time: implications for HIV trials. Sex Transm Dis 42:160-1

Showing the most recent 10 out of 125 publications